Details for Patent: 10,532,036
✉ Email this page to a colleague
Which drugs does patent 10,532,036 protect, and when does it expire?
Patent 10,532,036 protects COMBOGESIC and is included in one NDA.
This patent has twenty-five patent family members in nineteen countries.
Summary for Patent: 10,532,036
Title: | Combination composition |
Abstract: | A combination pharmaceutical composition for the treatment of pain including about 125 mg to about 150 mg ibuprofen and about 475 mg to about 500 mg paracetamol. |
Inventor(s): | Atkinson Hartley Campbell |
Assignee: | AFT Pharmaceuticals Limited |
Application Number: | US13857802 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 10,532,036
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aft Pharms Us | COMBOGESIC | acetaminophen; ibuprofen | TABLET;ORAL | 209471-001 | Mar 1, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | A METHOD OF TREATING MILD TO MODERATE ACUTE PAIN IN ADULTS BY ADMINISTERING 975-1000 MG OF ACETAMINOPHEN AND 292.5-300 MG OF IBUPROFEN IN A SINGLE ADMINISTRATION | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,532,036
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1781277 | ⤷ Sign Up | PA2024501 | Lithuania | ⤷ Sign Up |
Austria | E543491 | ⤷ Sign Up | |||
Australia | 2005260243 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |